3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
2
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Head & Neck
1
Conditions
Leukemia, Myeloid, Acute
18
Breast Neoplasms
17
Advanced Solid Tumors
16
Advanced Solid Tumor
12
Carcinoma, Non-Small-Cell Lung
10
Myelodysplastic Syndromes
8
Solid Tumor
6
Recurrence
6
Prostatic Neoplasms
6
Lymphoma, Large B-Cell, Diffuse
6
Uterine Cervical Neoplasms
5
Triple Negative Breast Neoplasms
5
Stomach Neoplasms
5
Ovarian Neoplasms
5
Carcinoma, Hepatocellular
5
Small Cell Lung Carcinoma
4
Myeloproliferative Disorders
4
Multiple Myeloma
4
Advanced Solid Tumour
4
Advanced Malignant Solid Tumor
4
Solid Tumors
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Neoplasms
3
Lymphoma, Non-Hodgkin
3
Lymphoma
3
Leukemia, Myelomonocytic, Chronic
3
Biliary Tract Neoplasms
3
Advanced Lung Cancer
3
Squamous Cell Carcinoma of Head and Neck
2
Sarcoma
2
Interventions
Magnetic Resonance Spectroscopy
12
Specimen Handling
10
Cisplatin
7
Radiation
6
pembrolizumab
5
Platinum
5
Biopsy
5
1,2-diaminocyclohexaneplatinum II citrate
5
Sentinel Lymph Node Biopsy
4
Drug Therapy
4
cemiplimab
3
X-Rays
3
Ultrasonography
3
Standard of Care
3
Radiotherapy, Intensity-Modulated
3
Radiotherapy
3
Cetuximab
3
Carboplatin
3
Taxes
2
Surgical Procedures, Operative
2
Practice Guidelines as Topic
2
Photons
2
Paclitaxel
2
Interviews as Topic
2
trastuzumab deruxtecan
1
toripalimab
1
technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran
1
sacituzumab govitecan
1
merphos
1
ipatasertib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Mouth Neoplasms
×
Injections
×
Clear all
NCT05966194
2024-11-15
KEVLARx
EpicentRx, Inc.
Phase 2
Recruiting
216 enrolled